Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 3 Other hematologic neoplasm 2 Breast 2 Thoracic 1 Plasma cell 1 Other neoplasm 1 Myeloid 1 Head & Neck 1

Conditions

Thyroid Neoplasms 1 Goiter 1

Interventions

Cisplatin 136 Cetuximab 101 pembrolizumab 83 Radiotherapy 62 Carboplatin 57 Radiotherapy, Intensity-Modulated 54 Fluorouracil 47 Docetaxel 47 Nivolumab 44 Paclitaxel 37 Radiation 21 Erlotinib Hydrochloride 19 durvalumab 18 Platinum 15 Ipilimumab 14 Gemcitabine 13 lenvatinib 12 Drug Therapy 12 Bevacizumab 12 Albumin-Bound Paclitaxel 12 vandetanib 11 Pemetrexed 11 Magnetic Resonance Spectroscopy 11 1,2-diaminocyclohexaneplatinum II citrate 11 Radiosurgery 10 Everolimus 10 tremelimumab 9 epacadostat 9 Surgical Procedures, Operative 9 Sorafenib 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Epinephrine × Head & Neck × Clear all

NCT02112370 2017-08-04

REBT

Seoul National University Hospital

Phase 3 Completed

148 enrolled 17 charts

Goiter, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡